Merck
Overview
Merck is a global healthcare company focused on prescription medicines, vaccines, biologic therapies, and animal health products. The company is a major player in the oncology sector, particularly through its flagship immunotherapy drug Keytruda.
Key Developments (2026)
- mRNA Cancer Vaccine Partnership: Merck has collaborated with moderna to develop personalized mRNA cancer vaccines.
- Trial Results: Positive Phase 3 trial results were announced for a personalized mRNA cancer vaccine (Intismeran Autogene) combined with Keytruda for adjuvant therapy in resected melanoma.
- Significance: This represents a significant advancement in combining mRNA technology with established immunotherapies to improve outcomes for cancer patients.
- Reference: Moderna Merck mRNA Cancer Vaccine and Keytruda for Resected Melanoma Adjuvant Therapy
- Source: Moderna Merck mRNA Cancer Vaccine and Keytruda for Resected Melanoma Adjuvant Therapy
Core Products & Therapies
- Keytruda (Pembrolizumab): A leading immune checkpoint inhibitor used in the treatment of various cancers, including melanoma, lung cancer, and head and neck cancers.
- Vaccines: Includes routine immunizations and emerging mRNA-based therapeutic vaccines.
Related Entities
- moderna
- Keytruda
- mRNA Technology
- Oncology
- Immunotherapy